Entera Bio Ltd.
ENTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $90,412 | $88,990 | $73,742 | $79,812 |
| - Cash | $8,574 | $10,858 | $12,573 | $8,660 |
| + Debt | $211 | $203 | $220 | $272 |
| Enterprise Value | $82,049 | $78,335 | $61,389 | $71,424 |
| Revenue | $0 | $0 | $42 | $82 |
| % Growth | – | -100% | -48.8% | – |
| Gross Profit | -$8 | $0 | $0 | $0 |
| % Margin | – | – | 0% | 0% |
| EBITDA | -$3,192 | -$2,661 | -$2,555 | -$2,326 |
| % Margin | – | – | -6,083.3% | -2,836.6% |
| Net Income | -$3,200 | -$2,656 | -$2,567 | -$2,358 |
| % Margin | – | – | -6,111.9% | -2,875.6% |
| EPS Diluted | 0.07 | -0.057 | 0.06 | -0.063 |
| % Growth | 223.5% | -194.5% | 195.2% | – |
| Operating Cash Flow | -$2,740 | -$1,646 | -$1,404 | -$1,467 |
| Capital Expenditures | -$46 | -$29 | -$8 | -$3 |
| Free Cash Flow | -$2,787 | -$1,675 | -$1,412 | -$1,470 |